Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies

被引：30

作者：

Ochoa, Sebastian ^{[1
]}

Ding, Li ^{[1
]}

Kreuzburg, Samantha ^{[1
]}

Treat, Jennifer ^{[2
]}

Holland, Steven M. ^{[1
]}

Zerbe, Christa S. ^{[1
]}

机构：

[1] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, Bethesda, MD 20892 USA

[2] Med Sci & Comp, Rockville, MD USA

来源：

CLINICAL INFECTIOUS DISEASES | 2021年 / 72卷 / 12期

基金：

美国国家卫生研究院;

关键词：

daratumumab; mycobacteria; disseminated; interferon gamma; autoantibodies;

D O I：

10.1093/cid/ciaa1086

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Patients with autoantibodies to interferon-gamma (IFN-gamma) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-gamma who had progressive infection, resulting in clinical and radiographic improvement.

引用

页码：2206 / 2208

页数：3

共 50 条

[1] Daratumumab (anti-CD38) For Treatment of Disseminated Nontuberculous Mycobacteria in a Patient with Anti-IFN-γ Autoantibodies
Ochoa, Sebastian
Li, Ding
Kreuzburg, Samantha
Treat, Jennifer
Holland, Steven
Zerbe, Christa
JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S78 - S79
[2] Bortezomib for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient with Anti-IFN-γ autoantibodies
Zerbe, Christa
Marciano, Betty
Treat, Jennifer
Kreuzburg, Samantha
Daub, Janine
Holland, Steven
JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S160 - S161
[3] Disseminated Talaromyces marneffei and Mycobacterium abscessus in a Patient With Anti-Interferon-γ Autoantibodies
Pruetpongpun, Nattapol
Khawcharoenporn, Thana
Damronglerd, Pansachee
Suthiwartnarueput, Worapop
Apisarnthanarak, Anucha
Rujanavej, Sasinuch
Suwantarat, Nuntra
OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (02):
[4] Anti-CD38 autoantibodies and diabetes
Raymondjean, M
M S-MEDECINE SCIENCES, 1998, 14 (10): : 1132 - 1133
[5] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
Richardson, P.
Lokhorst, H.
Palumbo, A.
Nahi, H.
Laubach, J.
Gimsing, P.
Lisby, S.
Cakana, A.
Brun, N. Constantin
Plesner, T.
DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
[6] Anti-CD38 autoantibodies in type? diabetes
Mallone, Roberto
Perin, Paolo Cavallo
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (04) : 284 - 294
[7] SUSTAINED RESPONSES TO ANTI-CD38 TREATMENT WITH DARATUMUMAB IN A PATIENT WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Alexander, T.
Ostendorf, L.
Biesen, R.
Radbruch, A.
Burmester, R.
Hiepe, F.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1459 - 1460
[8] Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon- autoantibodies and disseminated nontuberculous mycobacterial infections
Chi, Chih-Yu
Lin, Chia-Hao
Ho, Mao-Wang
Ding, Jing-Ya
Huang, Wen-Chi
Shih, Han-Po
Yeh, Chun-Fu
Fung, Chang-Phone
Sun, Hsin-Yun
Huang, Ching-Tai
Wu, Ting-Shu
Chang, Chih-Yen
Liu, Yuag-Meng
Feng, Jia-Yih
Wu, Wei-Kai
Wang, Lih-Shinn
Tsai, Chung-Hao
Ho, Cheng-Mao
Lin, Huang-Shen
Chen, Hung-Jen
Lin, Po-Chang
Liao, Wei-Chin
Chen, Wei-Ting
Lo, Chia-Chi
Wang, Shang-Yu
Kuo, Chen-Yen
Lee, Chen-Hsiang
Ku, Cheng-Lung
MEDICINE, 2016, 95 (25)
[9] Serological Investigation in a Multiple Myeloma Patient receiving Daratumumab (Anti-CD38)
Oldfield, L.
Ison, T.
Lau, W.
TRANSFUSION, 2016, 56 : 135A - 136A
[10] Rituximab as Successful Adjunct Treatment in a Patient With Disseminated Nontuberculous Mycobacterial Infection Due to Acquired Anti-Interferon-γ Autoantibody
Czaja, Christopher A.
Merkel, Patricai A.
Chan, Edward D.
Lenz, Laurel L.
Wolf, Molly L.
Alam, Rafeul
Frankel, Stephen K.
Fischer, Aryeh
Gogate, Shaila
Perez-Velez, Carlos M.
Knight, Vijaya
CLINICAL INFECTIOUS DISEASES, 2014, 58 (06) : E115 - E118

← 1 2 3 4 5 →